Literature DB >> 9111657

Transsynaptic degeneration of lateral geniculate bodies in blind children: in vivo MR demonstration.

C Uggetti1, M G Egitto, E Fazzi, P E Bianchi, F Zappoli, A Martelli, G Lanzi.   

Abstract

PURPOSE: To investigate signal alterations in the thalamic lateral geniculate bodies of blind patients compatible with transsynaptic degeneration of these nuclei caused by pregeniculate or postgeniculate interruption of the visual pathway.
METHODS: Six patients were selected from a group of blind children in our care. Four had cerebral palsy caused by periventricular leukomalacia, one had infantile neuroaxonal dystrophy, and one had Chiari I malformation and hydrocephalus, which was worsened by bilateral ischemic lesions of the occipital lobes. MR examinations (obtained at 0.5 T) were reviewed retrospectively by two neuroradiologists, with particular attention to the visual pathway.
RESULTS: Symmetric, focal areas of T2 prolongation were found at the precise site of the lateral geniculate bodies.
CONCLUSION: Anterograde (pregeniculate) and retrograde (postgeniculate) transsynaptic degeneration of the second neurons of the visual pathway produce alterations in MR signal.

Entities:  

Mesh:

Year:  1997        PMID: 9111657      PMCID: PMC8338592     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  15 in total

1.  Degeneration and plasticity of the optic pathway in Alström syndrome.

Authors:  R Manara; V Citton; P Maffei; J D Marshall; J K Naggert; G Milan; R Vettor; A Baglione; A Vitale; C Briani; F Di Salle; A Favaro
Journal:  AJNR Am J Neuroradiol       Date:  2014-10-29       Impact factor: 3.825

2.  Findings in a patient with herpes simplex viral meningitis associated with acute retinal necrosis syndrome.

Authors:  Y Tada; K Negoro; M Morimatsu; H Makino; T Nishida
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

Review 3.  Trans-synaptic Retrograde Degeneration in the Human Visual System: Slow, Silent, and Real.

Authors:  Marc Dinkin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

4.  NR2F1 mutations cause optic atrophy with intellectual disability.

Authors:  Daniëlle G M Bosch; F Nienke Boonstra; Claudia Gonzaga-Jauregui; Mafei Xu; Joep de Ligt; Shalini Jhangiani; Wojciech Wiszniewski; Donna M Muzny; Helger G Yntema; Rolph Pfundt; Lisenka E L M Vissers; Liesbeth Spruijt; Ellen A W Blokland; Chun-An Chen; Richard A Lewis; Sophia Y Tsai; Richard A Gibbs; Ming-Jer Tsai; James R Lupski; Huda Y Zoghbi; Frans P M Cremers; Bert B A de Vries; Christian P Schaaf
Journal:  Am J Hum Genet       Date:  2014-01-23       Impact factor: 11.025

Review 5.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

6.  Optic disc morphology may reveal timing of insult in children with periventricular leucomalacia and/or periventricular haemorrhage.

Authors:  L Jacobson; A-L Hård; E Svensson; O Flodmark; A Hellström
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

7.  Cone dysfunctions in retinitis pigmentosa with retinal nerve fiber layer thickening.

Authors:  Güngör Sobacı; Gökhan Ozge; Fatih Ç Gündoğan
Journal:  Clin Ophthalmol       Date:  2012-03-23

Review 8.  The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis.

Authors:  Fiona Costello
Journal:  ISRN Neurol       Date:  2013-11-06

9.  Relationship among Ocular Diseases, Developmental Levels, and Clinical Characteristics of Children with Diplegic Cerebral Palsy.

Authors:  Ahmet Boyaci; Ali Akal; Ahmet Tutoglu; Hasan Kandemir; Irfan Koca; Ismail Boyraz; Esra Celen; Ufuk Ozkan
Journal:  J Phys Ther Sci       Date:  2014-11-13

10.  Low vision due to cerebral visual impairment: differentiating between acquired and genetic causes.

Authors:  Daniëlle G M Bosch; F Nienke Boonstra; Michèl A A P Willemsen; Frans P M Cremers; Bert B A de Vries
Journal:  BMC Ophthalmol       Date:  2014-05-01       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.